Molecular Partners AG
MLLCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $123,841 | $114,342 | $185,144 | $559,252 |
| - Cash | $63,874 | $67,309 | $87,946 | $71,813 |
| + Debt | $2,444 | $3,652 | $4,850 | $6,039 |
| Enterprise Value | $62,411 | $50,685 | $102,048 | $493,478 |
| Revenue | $4,970 | $7,038 | $189,556 | $9,330 |
| % Growth | -29.4% | -96.3% | 1,931.7% | – |
| Gross Profit | -$42,534 | -$40,806 | $139,661 | -$45,630 |
| % Margin | -855.8% | -579.8% | 73.7% | -489.1% |
| EBITDA | -$51,647 | -$59,530 | $120,846 | -$60,670 |
| % Margin | -1,039.2% | -845.8% | 63.8% | -650.3% |
| Net Income | -$54,043 | -$61,984 | $117,853 | -$63,785 |
| % Margin | -1,087.4% | -880.7% | 62.2% | -683.7% |
| EPS Diluted | -1.63 | -1.89 | 3.54 | -2.06 |
| % Growth | 13.8% | -153.4% | 271.8% | – |
| Operating Cash Flow | -$59,248 | -$59,005 | $118,566 | -$90,953 |
| Capital Expenditures | -$723 | -$808 | -$1,417 | -$1,307 |
| Free Cash Flow | -$59,971 | -$59,813 | $117,149 | -$92,260 |